Stay updated on Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A minor site revision was applied (v3.3.4) with no visible changes to the study content or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:26:16.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Study status changed from 'Active, not recruiting' to 'Completed'. The page now lists a study completion date (2025-08-15) and an estimated last update posted date (2025-12) in the status section.
    Difference
    0.4%
    Check dated 2026-01-06T22:56:27.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Locations section now lists new sites in Illinois and New York and the revision version updated to v3.3.3. Older Illinois/New York locations and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.3%
    Check dated 2025-12-23T09:43:11.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Updated revision from v3.3.1 to v3.3.2; no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:44:05.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.2.0 to v3.3.1, with no changes to study content or details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:50:20.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Removed the banner about a lapse in government funding and related operating status notices. The study details and other trial information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:57:29.000Z thumbnail image

Stay in the know with updates to Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.